Publication	Data		Fish	Anatomy
Xie et al., 2024	Figure 4		myd88hu3568/hu3568	defense response to bacterium decreased efficacy, abnormal
Loes et al., 2021	Fig. 5		myd88b1354/b1354 (AB/TU)	whole organism il1b expression decreased amount, abnormal whole organism mmp9 expression decreased amount, abnormal
Cunha et al., 2020	Fig. 5		myd88hu3568; tum109Tg; ue2Tg	spinal cord single fate stem cell decreased amount, abnormal
Hsu et al., 2018	Fig. 5		nc1Tg + CRISPR7-myd88 + CRISPR8-myd88	positive regulation of NF-kappaB transcription factor activity decreased magnitude, abnormal
Troll et al., 2018	Fig. 3		myd88hu3568/+ ,   WT + MO2-myd88 ,   myd88hu3568/hu3568	posterior intestine goblet cell decreased amount, abnormal
	Fig. 4		WT + MO2-myd88	intestinal bulb peptide hormone secreting cell decreased amount, abnormal posterior intestine goblet cell decreased amount, abnormal
Burns et al., 2017	Fig. S1		myd88b1354/b1354 (AB/TU)	intestine neutrophil decreased amount, abnormal
Fehr et al., 2016	Fig. 8		WT + MO2-myd88	whole organism myd88 expression decreased amount, abnormal
He et al., 2015	Fig. 2		la2Tg + MO1-myd88 ,   myd88hu3568/hu3568 ,   TU + MO1-myd88	intermediate cell mass of mesoderm hematopoietic cell decreased amount, abnormal intermediate cell mass of mesoderm hematopoietic multipotent progenitor cell decreased amount, abnormal T cell decreased amount, abnormal ventral wall of dorsal aorta hematopoietic multipotent progenitor cell decreased amount, abnormal
	Fig. 3		TU + MO1-myd88 ,   hkz010tTg + MO1-myd88	ventral wall of dorsal aorta hematopoietic multipotent progenitor cell decreased amount, abnormal
	Fig. S3		la2Tg + CRISPR1-myd88 + CRISPR2-myd88 + CRISPR3-myd88 + CRISPR4-myd88 + CRISPR5-myd88	intermediate cell mass of mesoderm hematopoietic cell decreased amount, abnormal
van der Vaart et al., 2013	Fig. 1		myd88hu3568/hu3568 (AB)	activation of innate immune response decreased process quality, abnormal pattern recognition receptor signaling pathway decreased process quality, abnormal whole organism decreased life span, abnormal
	Fig. 6		WT + MO2-myd88 ,   myd88hu3568/hu3568 (AB)	activation of innate immune response decreased process quality, abnormal
	Fig. 7		myd88hu3568/hu3568 (AB)	activation of innate immune response decreased process quality, abnormal
Bates et al., 2007	Fig. 1		WT + MO2-myd88	alkaline phosphatase activity decreased occurrence, abnormal